.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Moodys
Johnson and Johnson
Fish and Richardson
Deloitte
Mallinckrodt
Teva
US Department of Justice
Chinese Patent Office
Healthtrust

Generated: June 22, 2017

DrugPatentWatch Database Preview

ZUPLENZ Drug Profile

« Back to Dashboard

Which patents cover Zuplenz, and what generic Zuplenz alternatives are available?

Zuplenz is a drug marketed by Midatech Pharma Us and is included in one NDA. There are two patents protecting this drug.

This drug has fourteen patent family members in ten countries.

The generic ingredient in ZUPLENZ is ondansetron. There are twenty-eight drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the ondansetron profile page.

Summary for Tradename: ZUPLENZ

Patents:2
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list77
Clinical Trials: see list1
Patent Applications: see list5,129
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZUPLENZ at DailyMed

Pharmacology for Tradename: ZUPLENZ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Midatech Pharma Us
ZUPLENZ
ondansetron
FILM;ORAL022524-001Jul 2, 2010RXYesNo8,580,830► SubscribeY ► Subscribe
Midatech Pharma Us
ZUPLENZ
ondansetron
FILM;ORAL022524-002Jul 2, 2010RXYesYes9,095,577► SubscribeY ► Subscribe
Midatech Pharma Us
ZUPLENZ
ondansetron
FILM;ORAL022524-001Jul 2, 2010RXYesNo9,095,577► SubscribeY ► Subscribe
Midatech Pharma Us
ZUPLENZ
ondansetron
FILM;ORAL022524-002Jul 2, 2010RXYesYes8,580,830► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: ZUPLENZ

Country Document Number Estimated Expiration
Germany202007019476► Subscribe
Australia2007304425► Subscribe
South Korea101448050► Subscribe
New Zealand575900► Subscribe
Canada2664986► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Teva
Novartis
Deloitte
Johnson and Johnson
Cerilliant
Healthtrust
Cipla
QuintilesIMS
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot